~~<i id='94FB338DBC'><strike id='94FB338DBC'><tt id='94FB338DBC'><pre id='94FB338DBC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：explore 2025-09-30 05:04:04 - browse：74289

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Humana, CVS hope to turn members into patients at clinics

explore

focus

Wikipedia

focus

entertainment

ProMEDmapScreengrabviaProMEDTheearlywarningdiseasenetworkthatalertedtheworldtotheoriginalSARSoutbrea

WSS

White House drug shortage group privately met with industry

Why did Pfizer dish out millions for a Super Bowl ad?

Industry veterans launch new biotech VC with $310M

Nearly two

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

How digital tools helped lower hypertension in marginalized patients

entertainment

entertainment

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

ChatGPT in medicine: STAT answers readers' burning questions

Doctors' information doesn't help them choose wisely when sick

Guidelines to prevent youth baseball injuries need more muscle

Doctors' information doesn't help them choose wisely when sick

Novavax promises a turnaround & Lilly roils the obesity market

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

After affirmative action ruling, medical educators look to 'holistic review'

For BCIs, commercial hurdles may be bigger than scientific ones

focus

Industry veterans launch new biotech VC with $310M

ER docs worry over extreme heat as a 'mass casualty event'

Dramatically reducing cancer deaths requires the PASTEUR Act

The drug industry sees a key ally in the Senate prevail

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

2 US Navy sailors arrested for allegedly spying for China

Wikipedia

focus

entertainment

entertainment